Dermatology
News
European Commission grants approval of ritlecitinib for severe alopecia areata
In June of 2023, ritlecitinib was approved by the FDA for treatment of severe alopecia areata in people ages 12 and older in the United States.
News
When treating scars, ‘rehabilitation’ is the goal, not perfection
Most scars respond best to treatments with ablative and nonablative fractional lasers tuned to gentle settings, according to Victor Ross, MD.
Article
Nonhealing postsurgical scalp ulcers
News
Company submits supplemental NDA for topical atopic dermatitis treatment
The development is based on results from two identical phase 3, vehicle-controlled trials.
Article
Small persistent leg wound
News
Ruxolitinib for vitiligo: Experts share experiences from first year
Many patients “don’t hit their optimal results at 3 months, 6 months, even the year mark. With continued use, many can see continued benefit,”...
News
FDA to step up oversight of cosmetics, assess ‘forever chemicals’
The cosmetic products include makeup products, nail polishes, shaving creams, other grooming products, perfumes, face and body cleansers, hair...
Article
Inner lip erosions
News
Dupilumab gains off-label uses as clinicians turn to drug for more indications
As the roster of approved and off-label indications grows, skin specialists said, pediatricians and other primary care providers should become...
News
EMA validates marketing authorization application for delgocitinib cream
Delgocitinib is being evaluated for the treatment of chronic hand eczema in adults.